Australia’s Apex Court Shuts Down Devas Investors’ USD 111 Million Claim Against India

A full bench of Australia’s highest court has delivered a significant ruling on the intersection of international arbitration enforcement and foreign state immunity, dismissing an attempt by Mauritian shareholders in Devas Multimedia Private Limited to enforce a USD 111 million arbitral award against the Republic of India. The seven-judge constitution bench, presided over by Chief Justice Stephen Gageler, held that a state’s accession to the 1958 New York Convention on the Recognition and Enforcement of Foreign Arbitral Awards does not, by itself, constitute an abandonment of sovereign immunity — a finding that carries considerable weight for India’s ongoing defence against multiple enforcement proceedings arising from the Antrix-Devas satellite spectrum dispute across several jurisdictions worldwide.

The factual matrix traces back to a 2005 commercial agreement between Antrix Corporation Limited — the commercial arm of the Indian Space Research Organisation — and Devas Multimedia, a Bengaluru-based company, for the lease of electromagnetic spectrum on satellites to deliver broadband and audio-visual services across India. The arrangement unravelled in 2011 when the Government of India annulled the contract, invoking national and strategic spectrum requirements. Mauritian investors holding equity in Devas subsequently initiated arbitral proceedings at The Hague in July 2012 under UNCITRAL Rules, arguing that the cancellation amounted to expropriation of their investments under the India-Mauritius Bilateral Investment Treaty, which had been signed in 1998 and entered into force on 20 June 2000. The arbitral tribunal, in a jurisdictional ruling dated 25 July 2016, upheld its authority to adjudicate the dispute and found India in breach of its treaty obligations. The proceedings culminated in a final award on 13 October 2020, directing India to pay compensation exceeding USD 111 million. Enforcement proceedings in Australia were launched on 21 April 2021.

The central legal question before the Australian High Court was deceptively narrow but carried systemic implications: does India’s ratification of the New York Convention operate as a waiver of its foreign state immunity in Australian courts? The appellants — represented by B.W. Walker SC alongside J.A. Hogan-Doran SC and A.F. Garsia, instructed by Norton Rose Fulbright — argued that by acceding to the Convention, India had submitted itself to the enforcement jurisdiction of every contracting state’s domestic courts. India, represented by J.T. Gleeson SC and F.T. Roughley SC with C.G. Winnett, instructed by White & Case, countered that sovereign immunity is a distinct body of law that the Convention neither addresses nor overrides. The Commonwealth of Australia intervened through Solicitor-General S.P. Donaghue KC with C.S.A. Harris and A.A.E. O’Beid, instructed by the Australian Government Solicitor.

The Court came down firmly in favour of the immunity defence. It reasoned that while foreign state immunity in many jurisdictions — Australia included — is not absolute and admits of exceptions where local courts retain jurisdiction over foreign states as part of territorial sovereignty, a robust presumption operates against any inference that a foreign state has relinquished that protection. Any waiver, the Court held, must be established to a standard that is unambiguous and unmistakable. The Court found that no such waiver could be derived from India’s ratification of the New York Convention. It turned to Article III of the Convention, which governs the obligation of contracting states to recognise and enforce awards, and concluded that this provision expressly preserves the application of domestic procedural rules — including foreign state immunity statutes — in the territory where enforcement is sought. The Convention’s text and drafting history, the Court observed, contain no express reference to the displacement of sovereign immunity, and no interpretation to that effect could be sustained.

Notably, the Court declined to engage with the broader question of the Convention’s substantive scope — a matter that had attracted academic and practitioner attention — holding that since the immunity point was dispositive, there was no occasion to explore questions that had not been fully ventilated. The bench observed that such issues ought to be resolved in a future case where they prove determinative and have been thoroughly examined.

The practical consequence of this judgment extends well beyond the Antrix-Devas dispute. Devas investors have pursued enforcement of the same award across multiple national courts, and the Australian ruling now stands as the most authoritative apex court pronouncement on whether Convention membership entails a jurisdictional concession by sovereign states. For India, which has been defending against these enforcement attempts on several fronts, the decision provides a powerful precedent. For the international arbitration community, it reinforces the understanding that the New York Convention is an enforcement facilitation mechanism, not a device for circumventing the settled doctrine of sovereign immunity — a distinction that sovereign respondents in investment treaty arbitrations will undoubtedly rely upon in future enforcement battles across common law and civil law jurisdictions alike.


Leave a Reply

Your email address will not be published. Required fields are marked *